BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11381256)

  • 21. The role of SH3BP2 in the pathophysiology of cherubism.
    Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism].
    Deckert M; Prod'Homme V
    Med Sci (Paris); 2015; 31(6-7):589-91. PubMed ID: 26152156
    [No Abstract]   [Full Text] [Related]  

  • 23. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.
    Wang CJ; Chen IP; Koczon-Jaremko B; Boskey AL; Ueki Y; Kuhn L; Reichenberger EJ
    Bone; 2010 May; 46(5):1306-15. PubMed ID: 20117257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the SH3BP2 gene mutation in cherubism.
    Lee JY; Jung YS; Kim SA; Lee SH; Ahn SG; Yoon JH
    Acta Med Okayama; 2008 Jun; 62(3):209-12. PubMed ID: 18596838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.
    Argyris PP; Gopalakrishnan R; Hu Y; Reichenberger EJ; Koutlas IG
    Head Neck Pathol; 2018 Mar; 12(1):136-144. PubMed ID: 28721660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of B cell adaptor for PI3-kinase (BCAP) as an Abl interactor 1-regulated substrate of Abl kinases.
    Maruoka M; Suzuki J; Kawata S; Yoshida K; Hirao N; Sato S; Goff SP; Takeya T; Tani K; Shishido T
    FEBS Lett; 2005 Jun; 579(14):2986-90. PubMed ID: 15893754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.
    Idowu BD; Thomas G; Frow R; Diss TC; Flanagan AM
    Br J Oral Maxillofac Surg; 2008 Apr; 46(3):229-230. PubMed ID: 17544554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gene mutation and expression of SH-3BP-2 in cherubism].
    Li YW; Meng XM; Yu SF; Gao P
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Apr; 44(4):227-31. PubMed ID: 19576004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.
    Yoshitaka T; Kittaka M; Ishida S; Mizuno N; Mukai T; Ueki Y
    Bone; 2015 Feb; 71():201-9. PubMed ID: 25445458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss.
    Yoshitaka T; Ishida S; Mukai T; Kittaka M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014; 29(5):1170-82. PubMed ID: 24978678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cherubism - new hypotheses on pathogenesis and therapeutic consequences.
    Hyckel P; Berndt A; Schleier P; Clement JH; Beensen V; Peters H; Kosmehl H
    J Craniomaxillofac Surg; 2005 Feb; 33(1):61-8. PubMed ID: 15694152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
    Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
    J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cherubism: best clinical practice.
    Papadaki ME; Lietman SA; Levine MA; Olsen BR; Kaban LB; Reichenberger EJ
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S6. PubMed ID: 22640403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic aspects of cherubism].
    Brix M; Peters H; Ranfaing E; Ricbourg B
    Rev Stomatol Chir Maxillofac; 2006 Apr; 107(2):105-8. PubMed ID: 16738517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.
    Yoshimoto T; Hayashi T; Kondo T; Kittaka M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2018 Aug; 33(8):1513-1519. PubMed ID: 29669173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A c.1244G>A (p.Arg415Gln) mutation in SH3BP2 gene causes cherubism in a Turkish family: report of a family with review of the literature.
    Sekerci AE; Balta B; Dundar M; Hu Y; Reichenberger EJ; Etoz OA; Nazlim S; Bayrakdar IS
    Med Oral Patol Oral Cir Bucal; 2014 Jul; 19(4):e340-4. PubMed ID: 24608212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathologic study of a family cherubism].
    Meng XM; Yu SF; Wu YT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Nov; 39(6):475-7. PubMed ID: 15854318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cherubism as a systemic skeletal disease: evidence from an aggressive case.
    Morice A; Joly A; Ricquebourg M; Maruani G; Durand E; Galmiche L; Amiel J; Vial Y; Cavé H; Belhous K; Piketty M; Cohen-Solal M; Berdal A; Collet C; Picard A; Coudert AE; Kadlub N
    BMC Musculoskelet Disord; 2020 Aug; 21(1):564. PubMed ID: 32825821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.